• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Maximal immune response and cross protection by influenza virus nucleoprotein derived from E. coli using an optimized formulation

tetano

Editor, Senior Moderator
Virology. 2014 Sep 8;468-470C:265-273. doi: 10.1016/j.virol.2014.08.008. [Epub ahead of print]
Maximal immune response and cross protection by influenza virus nucleoprotein derived from E. coli using an optimized formulation.
Wang W1, Huang B1, Jiang T1, Wang X1, Qi X1, Tan W1, Ruan L2.
Author information
Abstract

The highly conserved internal nucleoprotein (NP) is a promising antigen to develop a universal influenza A virus vaccine. In this study, mice were injected intramuscularly with Escherichia coli-derived NP protein alone or in combination with adjuvant alum (Al(OH)3), CpG or both. The results showed that the NP protein formulated with adjuvant was effective in inducing a protective immune response. Additionally, the adjuvant efficacy of Al(OH)3 was stronger than that of CpG. Optimal immune responses were observed in BALB/c mice immunized with a combination of NP protein plus Al(OH)3 and CpG. These mice also showed maximal resistance following challenge with influenza A virus PR8 strain. Most importantly, 10?g NP formulated with Al(OH)3 and CpG induced higher protection than did 90?g NP. These findings indicated that a combination of Al(OH)3 and CpG may be an efficient adjuvant in the NP formulation.

Copyright ? 2014 Elsevier Inc. All rights reserved.
KEYWORDS:

Al(OH)(3); CpG; Influenza A virus; Nucleoprotein; Protective immunity; Protein subunit vaccines

PMID:
25213406
[PubMed - as supplied by publisher]

http://www.ncbi.nlm.nih.gov/pubmed/25213406
 
Back
Top Bottom